tiprankstipranks
Virax Biolabs Group Ltd. Class A (VRAX)
NASDAQ:VRAX
US Market

Virax Biolabs Group Ltd. Class A (VRAX) Balance Sheet

Compare
104 Followers

Virax Biolabs Group Ltd. Class A Balance Sheet

Virax Biolabs Group Ltd. Class A's total assets for Q4 2024 were $5.48M, a decrease of -21.94% from the previous quarter. VRAX total liabilities were $345.19K for the fiscal quarter, a -62.44% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Assets
$ 5.48M$ 9.81M$ 48.71K$ 94.12K$ 22.61K
Total Liabilities
$ 345.19K$ 908.40K$ 1.25M$ 871.43K$ 1.24M
Total Equity Gross Minority
$ 5.14M$ 8.90M$ -1.20M$ -777.32K$ -1.22M
Other Metrics
$ ―$ ―$ ―$ ―$ ―
Currency in USD

Virax Biolabs Group Ltd. Class A Debt to Assets

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis